Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovastatin in temporal lobe drug resistant epilepsy
NCT06789497Completed
- Sponsor
- University of Coimbra
- Start
- Jan 2020
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in temporal lobe epilepsy (TLE) comparing Lovastatin with Placebo (2 arms). Primary endpoints: Neurochemical response changes to GABAergic stimulation at Day 4, Evaluation of neuroinflammation by measuring Glutathione at Day 4 and 2 more. Started Jan 2020; status: completed.
02
Drugs
lovastatin
03
Conditions
temporal lobe epilepsy (TLE)
Beyond the preview
Go deeper on NCT06789497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06789497.